home / stock / idya / idya message board
Subject | By | Source | When |
---|---|---|---|
$THER STOCK CANCER GOOD NEWS | Jayzp | investorshub | 04/24/2023 12:39:39 PM |
Finally some pub. Just take something to | Poshfox | investorshub | 09/02/2020 10:49:52 PM |
$60 million becomes $100 offering. | Laster | investorshub | 06/18/2020 2:07:55 AM |
POS company gets $100 million and then announces | Laster | investorshub | 06/17/2020 12:26:28 AM |
Awesome press release, lets see where this goes | dinogreeves | investorshub | 06/16/2020 12:19:43 PM |
We have made significant progress on our Phase | xr_biotech_consult | investorshub | 11/13/2019 8:42:45 PM |
IDEAYA anticipates that existing cash, cash equivalents and | xr_biotech_consult | investorshub | 11/13/2019 8:39:51 PM |
has anyone bought except me? big day today | xr_biotech_consult | investorshub | 11/13/2019 7:31:14 PM |
spec. buy | xr_biotech_consult | investorshub | 11/05/2019 5:47:08 PM |
News, Short Squeeze, Breakout and More Instantly...
IDEAYA Biosciences Inc. Company Name:
IDYA Stock Symbol:
NASDAQ Market:
IDEAYA Biosciences Inc. Website:
IDEAYA Biosciences, Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update PR Newswire Enrollment in darovasertib + crizotinib 1L HLA-A2+ MUM potential Ph2/3 registration-enabling trial is ahead of schedule and has exceeded 150 patients Successful F...
2024-11-02 06:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors PR Newswire IDE275 (GSK959) development is progressing into First-in-Human Phase 1 clinical trial(s) for the treatment of MSI-High ...